Abstract
BACKGROUND: Gonadoblastoma (GB) is regarded as an in situ form of germ cell tumor in dysgenetic gonads, and 30% of patients with GB develop a dysgerminoma/seminoma tumor. OBJECTIVE: Determine whether OCT3/4 and β-catenin are expressed in dysgenetic gonads before GB development and whether TSPY participates in the OCT3/4-β-catenin pathways in the malignant invasive behavior. METHODS: dysgenetic gonads of Disorders of sex differentiation (DSD) patients with mixed gonadal dysgenesis were analyzed by immunohistochemistry and immunofluorescence for comparison with GB and dysgerminoma/seminoma. RESULTS: Our results suggest that the development of GB is secondary to the interaction of OCT3/4 and TSPY, that β-catenin does not participate in this process. CONCLUSIONS: The use of this biological markers detects the potential high risk gonads.
Original language | English |
---|---|
Pages (from-to) | 419-424 |
Number of pages | 6 |
Journal | Disease Markers |
Volume | 34 |
Issue number | 6 |
DOIs | |
State | Published - 2013 |
Keywords
- Gonadoblastoma
- OCT3/4
- TSPY
- dysgenetic gonads
- mixed gonadal dysgenesis
- β-catenin